Similar articles

• Beginning to make progress against HIV.

  Wilfert CM. Wilfert CM. N Engl J Med. 1996 Nov 28;335(22):1678-80. doi: 10.1056/NEJM199611283352210. N Engl J Med. 1996. PMID: 8929367 No abstract available.
• Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

  Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA 3rd, Whitehouse J, Moye J Jr, Reichelderfer P, Harris DR, Fowler MG, Mathieson BJ, Nemo GJ. Mofenson LM, et al. N Engl J Med. 1999 Aug 5;341(6):385-93. doi: 10.1056/NEJM199908053410601. N Engl J Med. 1999. PMID: 10432323 Clinical Trial.
• HIV infection and pregnancy.

  de Ruiter A, Brocklehurst P. de Ruiter A, et al. Int J STD AIDS. 1998 Nov;9(11):647-54; quiz 655. doi: 10.1258/0956462981921288. Int J STD AIDS. 1998. PMID: 9863576 Review. No abstract available.
• [Vertical transmission of HIV treated with zidovudine in county hospitals in Catalonia].

  Tapiz A, Dorca E, Force L, Aranda M. Tapiz A, et al. Med Clin (Barc). 1999 Sep 25;113(9):357. Med Clin (Barc). 1999. PMID: 10562932 Spanish. No abstract available.
• Preventing perinatal HIV transmission: zidovudine use during pregnancy.

  Carmichael C. Carmichael C. Am Fam Physician. 1997 Jan;55(1):171-4, 177-8. Am Fam Physician. 1997. PMID: 9012276 Review.